Inter-observer variability of clinical target volume delineation in definitive radiotherapy of neck lymph node metastases from unknown primary. A cooperative study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Head and Neck Group.


Journal

La Radiologia medica
ISSN: 1826-6983
Titre abrégé: Radiol Med
Pays: Italy
ID NLM: 0177625

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 31 10 2018
accepted: 11 02 2019
pubmed: 11 3 2019
medline: 13 7 2019
entrez: 11 3 2019
Statut: ppublish

Résumé

This study, promoted by Italian Association of Radiotherapy and Clinical Oncology (AIRO) Head and Neck Group, aimed to assess the current national practice of target volume delineation on a case of neck lymph node metastases from unknown primary evaluating inter-observer variability, in a setting of primary radiotherapy. A case of metastatic neck lymph node from occult primary was proposed to 17 radiation oncologists. A national reference RT center was identified and considered as benchmark. Participants were requested to delineate target volumes. A structured questionnaire was administered. A comparison between following parameters of the CTVs was performed: centroids distances, Dice similarity index (DSI), Jaccard index and mean distance to agreement (MDA). Volume expressed in cubic centimeters and CTVs cranio-caudal extension were evaluated. Sixteen of 17 radiation oncologists recommended three CTVs dose levels. (CTV HD, CTV ID and CTV LD); CTV ID was not delineated by one of the participants and by the reference center. The distance between the reference centroid and the mean centroid of CTVs HD was 1.09 cm (0.36-3.99 cm); for CTV LD, a mean centroids distance of 2.45 (0.27-4.83 cm) was found, and for CTV HD, mean DSI is 0.48 and mean Jaccard index is 0.32 and MDA was 8.89 mm. CTV LD showed a mean DSI of 0.46, mean Jaccard index of 0.31 and MDA of 14.87 when compared to the reference. Many aspects concerning treatment optimization of cervical nodes metastases from occult primary remain unclear, and we found a notable heterogeneity of global radiotherapy management reporting discordances both in target volume delineation and volume prescription.

Sections du résumé

BACKGROUND BACKGROUND
This study, promoted by Italian Association of Radiotherapy and Clinical Oncology (AIRO) Head and Neck Group, aimed to assess the current national practice of target volume delineation on a case of neck lymph node metastases from unknown primary evaluating inter-observer variability, in a setting of primary radiotherapy.
MATERIALS AND METHODS METHODS
A case of metastatic neck lymph node from occult primary was proposed to 17 radiation oncologists. A national reference RT center was identified and considered as benchmark. Participants were requested to delineate target volumes. A structured questionnaire was administered. A comparison between following parameters of the CTVs was performed: centroids distances, Dice similarity index (DSI), Jaccard index and mean distance to agreement (MDA). Volume expressed in cubic centimeters and CTVs cranio-caudal extension were evaluated.
RESULTS RESULTS
Sixteen of 17 radiation oncologists recommended three CTVs dose levels. (CTV HD, CTV ID and CTV LD); CTV ID was not delineated by one of the participants and by the reference center. The distance between the reference centroid and the mean centroid of CTVs HD was 1.09 cm (0.36-3.99 cm); for CTV LD, a mean centroids distance of 2.45 (0.27-4.83 cm) was found, and for CTV HD, mean DSI is 0.48 and mean Jaccard index is 0.32 and MDA was 8.89 mm. CTV LD showed a mean DSI of 0.46, mean Jaccard index of 0.31 and MDA of 14.87 when compared to the reference.
CONCLUSION CONCLUSIONS
Many aspects concerning treatment optimization of cervical nodes metastases from occult primary remain unclear, and we found a notable heterogeneity of global radiotherapy management reporting discordances both in target volume delineation and volume prescription.

Identifiants

pubmed: 30852793
doi: 10.1007/s11547-019-01006-y
pii: 10.1007/s11547-019-01006-y
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

682-692

Références

Radiother Oncol. 2000 May;55(2):121-9
pubmed: 10799723
Radiother Oncol. 2000 Jul;56(1):73-83
pubmed: 10869758
Acta Oncol. 2001;40(1):50-5
pubmed: 11321661
Int J Radiat Oncol Biol Phys. 2001 Jul 1;50(3):727-33
pubmed: 11395241
Eur J Cancer. 2002 Feb;38(3):409-13
pubmed: 11818207
Int J Radiat Oncol Biol Phys. 2002 Jul 1;53(3):766-74
pubmed: 12062623
Eur J Cancer. 2002 Sep;38(13):1810-2
pubmed: 12175699
Eur J Cancer. 2003 Sep;39(14):1990-2005
pubmed: 12957453
Am J Clin Oncol. 2006 Dec;29(6):606-12
pubmed: 17148999
Head Neck. 2008 Jan;30(1):28-34
pubmed: 17657782
Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1051-8
pubmed: 17716824
Radiother Oncol. 2008 May;87(2):281-9
pubmed: 18279984
J Clin Oncol. 2008 Aug 1;26(22):3770-6
pubmed: 18669465
Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1166-70
pubmed: 19836158
Arch Otolaryngol Head Neck Surg. 2009 Oct;135(10):1024-9
pubmed: 19841343
Radiother Oncol. 2009 Dec;93(3):483-7
pubmed: 19892420
Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1005-10
pubmed: 20207504
Radiother Oncol. 2010 Dec;97(3):572-8
pubmed: 20708285
Clin Oncol (R Coll Radiol). 2011 Mar;23(2):108-13
pubmed: 21093228
Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1866-71
pubmed: 21497452
Strahlenther Onkol. 2011 Jun;187(6):357-66
pubmed: 21603989
Strahlenther Onkol. 2012 Feb;188(2):160-7
pubmed: 22281878
J Med Imaging Radiat Oncol. 2012 Apr;56(2):195-203
pubmed: 22498194
Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):e245-9
pubmed: 22583602
Br J Radiol. 2012 Aug;85(1016):1070-7
pubmed: 22815411
Z Med Phys. 2013 Dec;23(4):279-90
pubmed: 23969092
Radiother Oncol. 2014 Jan;110(1):172-81
pubmed: 24183870
Cancer Radiother. 2014 Mar;18(2):89-96
pubmed: 24440683
Radiat Oncol. 2014 Aug 03;9:173
pubmed: 25086641
Radiat Oncol. 2014 Sep 08;9:198
pubmed: 25199768
Radiat Oncol. 2014 Dec 29;9:264
pubmed: 25544268
J Med Imaging Radiat Oncol. 2016 Jun;60(3):393-406
pubmed: 27170216
Oncotarget. 2016 Nov 29;7(48):78736-78746
pubmed: 27791201
J Laryngol Otol. 2016 May;130(S2):S161-S169
pubmed: 27841133
Radiat Oncol. 2017 May 10;12(1):82
pubmed: 28486947
Jpn J Clin Oncol. 2017 Sep 1;47(9):856-862
pubmed: 28903529
Arch Otolaryngol Head Neck Surg. 1994 Jul;120(7):699-702
pubmed: 8018319
Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):797-802
pubmed: 9128954

Auteurs

Marianna Trignani (M)

Department of Radiation Oncology, SS. Annunziata Hospital, "G. D'Annunzio" University of Chieti, Chieti, Italy. marianna.trignani@unich.it.

Angela Argenone (A)

Radiation Oncology Department, Istituto Nazionale Tumori-IRCSS-Fondazione G. Pascale, Naples, Italy.

Saide Di Biase (S)

Department of Radiation Oncology, SS. Annunziata Hospital, "G. D'Annunzio" University of Chieti, Chieti, Italy.

Daniela Musio (D)

Radiation Oncology Department, Ospedale Policlinico Umberto I, Rome, Italy.

Anna Merlotti (A)

Radiation Oncology Department, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy.

Stefano Ursino (S)

Radiation Oncology Department, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.

Ester Orlandi (E)

Radiation Oncology Department, Fondazione IRCCS-Istituto Nazionale dei Tumori, Milan, Italy.

Domenico Genovesi (D)

Department of Radiation Oncology, SS. Annunziata Hospital, "G. D'Annunzio" University of Chieti, Chieti, Italy.

Almalina Bacigalupo (A)

Radiation Oncology Department, Ospedale Policlinico San Martino, Università di Genova, Genoa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH